- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 12.67M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 12.79M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 10.98M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.16M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $7.74M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.85M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $6.59M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $8.03M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $10.58M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $48.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $46.55M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $53.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $59.57M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $61.44M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $69.74M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $30.48M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $35.44M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $111.87M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $118.08M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.18 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.18 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $24.99M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $24.3M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $228.82K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $0 |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.17M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$258.22K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.16M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$106.02K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $28.14M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $24.2M |
| Revenue | Q1 2026 · Mar 31, 2026 | $50.1M |
| Revenue | Q1 2026 · Mar 31, 2025 | $42.72M |